4//SEC Filing
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 4
Accession 0000950170-23-064519
CIK 0001966494other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 4:19 PM ET
Size
7.1 KB
Accession
0000950170-23-064519
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Stock
2023-11-14+737,000→ 737,000 total - Conversion
Series A-1 Preferred Stock
2023-11-14−10,000,000→ 0 total→ Common Stock (737,000 underlying)
Footnotes (1)
- [F1]Upon the closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 13.5685-for-one basis. The Series A-1 Preferred Stock had no expiration date.
Documents
Issuer
CARGO Therapeutics, Inc.
CIK 0001966494
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001903360
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 4:19 PM ET
- Size
- 7.1 KB